Gemini Pharmaceuticals, Inc.: due-diligence report
Public-record summary and buyer worksheet. Records can be incomplete; a listing is not product approval, an audit result or a guarantee of suitability. This report updates as source records change. Print a dated copy to retain the version you reviewed.
Share this report: https://certifiedmanufacturers.com/manufacturers/gemini-pharmaceuticals/due-diligence
Profile last verified: Nov 19, 2026. Report printed / reviewed on: ____________________
Certifications and licences
NSF/ANSI 455-2 GMP for Dietary Supplements
Issuer: NSF. Registry status: active. Checked: Nov 19, 2026.
Reference: Not recorded. Expiry: Not recorded.
Scope: Not recorded here; confirm with the registry and manufacturer.
Registry source: https://info.nsf.org/Certified/455GMP/Listings.asp?USDA Organic certified operation
Issuer: USDA Agricultural Marketing Service. Registry status: active. Checked: Nov 1, 2026.
Reference: 5520228201. Expiry: Not recorded.
Scope: Not recorded here; confirm with the registry and manufacturer.
Registry source: https://organic.ams.usda.gov/integrity/Facilities
Gemini Pharmaceuticals, Inc., 87 Modular Avenue, Commack, NY, 11725, US — manufacturing; source: NSF/ANSI 455-2; checked Nov 19, 2026.
Gemini Pharmaceuticals, Inc., 55 Adams Avenue, Commack, NY, 11725, US — manufacturing; source: NSF/ANSI 455-2; checked Nov 19, 2026.
Gemini Pharmaceuticals, Inc., 65 Mall Drive, Commack, NY, 11725, US — manufacturing; source: NSF/ANSI 455-2; checked Nov 19, 2026.
Gemini Pharmaceuticals, Inc., 65 Mall Drive, Commack, NY, 11725, US — distribution; source: NSF/ANSI 455-2; checked Nov 19, 2026.
FDA inspection history
Dataset date: Oct 28, 2026. Facility records are matched by company and location; confirm that the site is the one in your quote. FDA inspection source.
May 15, 2026 — VAI: Voluntary action indicated
Gemini Pharmaceuticals, Inc., Commack, New York, United States. FEI: 2432926; inspection: 1317530.
Food Composition, Standards, Labeling and Econ
21 CFR 111.70(b): Specifications - components
21 CFR 111.70(e): Specifications - finished dietary supplement
21 CFR 111.75(a)(2)(ii)(A): Component - qualify supplier
21 CFR 111.75(d)(1): Documentation specifications met; exempted, periodic testing
21 CFR 111.260: Batch record - required information
21 CFR 111.315(b): Sampling plans; establish, follow
21 CFR 111.315(d): Standard reference materials; criteria for selecting
Jul 26, 2022 — VAI: Voluntary action indicated
Gemini Pharmaceuticals, Inc., Commack, New York, United States. FEI: 2432926; inspection: 1175407.
Food Composition, Standards, Labeling and Econ, Foodborne Biological Hazards
21 CFR 111.75(c): Specifications met - verify; finished batch
Aug 23, 2018 — NAI: No action indicated
Gemini Pharmaceuticals, Inc., Commack, New York, United States. FEI: 2432926; inspection: 1064447.
Food Composition, Standards, Labeling and Econ
FDA recalls
Dataset date: Nov 19, 2026. Recall matches use company names and may concern a different product or facility.
No matched recall events in the imported dataset. This is not proof of a recall-free history.
Company website claims — not registry verified
Last website check: Oct 16, 2026.
“Gut Health Digestive Health Probiotics”
Last seen Oct 16, 2026. https://geminipharm.com/dietary-supplements/
“Common Products We Manufacture Include: Cognitive Health Beauty From Within Anti-Aging Longevity Mushrooms Collagen”
Last seen Oct 16, 2026. https://geminipharm.com/dietary-supplements/
“Multivitamins Prenatal Vitamins Letter Vitamins Minerals”
Last seen Oct 16, 2026. https://geminipharm.com/dietary-supplements/
“We specialize in developing high quality, unique formulations (including condition-specific) and line-extensions for customers in the United States and around the world.”
Last seen Oct 16, 2026. https://geminipharm.com/dietary-supplements/
“Worldwide Leader in Contract Manufacturing and Product Development”
Last seen Oct 16, 2026. https://geminipharm.com/
“Capabilities include bottling with pressure sensitive labels, shrink sleeve labels, silk screened packaging, display cartons, blister cards, sachets, and custom assembly options.”
Last seen Oct 16, 2026. https://geminipharm.com/packaging/
“This is affirmation by the leading organizations that we provide non- GMO products to the market”
Last seen Oct 16, 2026. https://geminipharm.com/gemini-pharmaceuticals-expands-capabilities-to-offer-clients-non-gmo-project-verified-products/
“Gemini manufactures products in compliance with both Kosher and Halal requirements.”
Last seen Oct 16, 2026. https://geminipharm.com/gemini-pharmaceuticals-expands-capabilities-to-offer-clients-non-gmo-project-verified-products/
“Gemini processes and handles products that qualify for the Organic Certification seal.”
Last seen Oct 16, 2026. https://geminipharm.com/gemini-pharmaceuticals-receives-organic-facility-certification-from-quality-assurance-international/
Evidence to request from the manufacturer
Public records cannot answer these questions. Mark each item after reviewing the evidence. Blank means not assessed, not a failed audit. Notes entered here are not saved or included in a shared URL.
Request role-specific training records and the named quality contact.
21 CFR 111.12Request a site walkthrough, sanitation controls and equipment maintenance records (also §111.25).
21 CFR 111.20Request written identity, purity, strength, composition and contaminant specifications for your product.
21 CFR 111.70Ask how each dietary ingredient is identified and how suppliers and certificates of analysis are qualified.
21 CFR 111.75Request quality control procedures, release authority and handling of deviations and rejected batches.
21 CFR 111.105Request the approved product-specific master manufacturing record and change-control process.
21 CFR 111.205Review a completed batch record with traceability to components, processing and release.
21 CFR 111.255Request scientifically valid test methods, sampling plans and laboratory controls for your specifications.
21 CFR 111.315Request procedures that prevent label mix-ups and control packaging and label reconciliation.
21 CFR 111.403Ask how storage conditions protect identity, purity, strength and composition during holding and distribution.
21 CFR 111.453Request complaint review and investigation procedures; discuss returned-product controls under §111.503.
21 CFR 111.553Confirm retention and access to records supporting your batches.
21 CFR 111.605